|
Enter a Search String | | Special character and space not allowed in the query term.
Search string should be at least 2 characters long. |
Molecule Parameter List for E.P_in | The statistics table lists the distribution of a molecule acting either as a substrate, product, enzyme or as a molecule within the network.
The text color of a molecule is highlighted by  color. | | Statistics |
| E.P_in participated as | Molecule | Sum total of | Enzyme | Substrate of an enzyme | Product of an enzyme | Substrate in Reaction | Product in Reaction | | No. of occurrences | 1 | 0 | 0 | 0 | 0 | 0 | 1 |
Accession and Pathway Details | |
| Accession Name | Accession No. | Accession Type | Pathway Link | | luciferase | 36 | Pathway |
luciferase | | This model is based on L. Yu. Brovko et al 1994, Biochemistry (Moscow) 59(2):195-201, 1994. The model replicates reaction scheme 3, and uses rates from table 2, but there are discrepancies in simulated results both with their simulations (fig 4) and with their experimental data. The overall time-course and luciferase dependence of luminiscence (Figs 1, 2, 3a) are reasonable semi-quantitative matches. |
E.P_in acting as a Molecule in luciferase Network
| Name | Accession Name | Pathway Name | Initial Conc.
(uM) | Volume
(fL) | Buffered | | E.P_in | luciferase
Accession No. : 36 | luciferase
Pathway No. : 186 | 0 | 999980000000 | No | | |
E.P_in acting as a Product in a reaction in luciferase Network
| Kd is calculated only for second order reactions, like nA+nB <->nC or nA<->nC+nD, where n is number and A,B,C,D are molecules, where as for first order reactions Keq is calculated.
Kd for higher order reaction are not consider. |
| Name | Accession Name | Pathway Name | Kf | Kb | Kd | tau | Reagents | | k6 | luciferase
Accession No. : 36 | luciferase
Pathway No. : 186 | 0.0003
(s^-1) | 0
(s^-1) | - | - | Substrate
E.P
Product
E.P_in
|
| Database compilation and code copyright (C) 2022, Upinder S. Bhalla and NCBS/TIFR
This Copyright is applied to ensure that the contents of this database remain freely available. Please see FAQ for details. |
|
